Investigation of proto-oncogene function in normal development as opposed to tumorigenesis is now possible by using embryonic stem cell technology to examine the results of mutation in specific oncogenes in a physiological context. Gene targeting in embryonic stem cells has been used to generate mice with a mutation in the c-myc proto-oncogene. This mutation is lethal in the homozygous state by 10.5 days of gestation. Of the 28 homozygous embryos analyzed, 86% showed evidence of cardiac failure. Since the c-myc phenotype has other abnormalities in addition to cardiac malfunction, the first goal of this proposal is to determine whether the cardiac defect is due to the c-myc mutation in cells destined to form the heart. To this end, rescue of c-myc mutant mice will be attempted with a c-myc transgene which is expressed in cardiac tissue only. Development can be viewed as a balance between proliferation and differentiation, and in vivo evidence suggests a role for c-myc in that relationship. The failure of cardiac development may be due to a lack of division of myocardial cell precursors, failure to differentiate into contractile tissue, or an inability to respond to growth factors associated with cardiac development. Homozygous c-myc mutant embryonic stem cell lines have been generated and will be used to analyze the differentiation capacity of c-myc deficient cells in tissue culture, in teratocarcinomas, and in chimeric embryos. In addition, other potentially hypomorphic alleles will be generated. These will be useful to dissect the relationship between c-myc protein lack of function and phenotype and between myc family members. Specifically homologous recombination in ES cells will be used to replace the c-myc coding sequence with N-myc coding sequences. Comparison with the c-myc null phenotype will allow us to test the ability of N-myc to substitute for c-myc function in a physiological context. In addition, a mutation which allows only the smaller of the two myc translation products to be made will be generated by the hit and run method.
| Liu, Yu; Kaneda, Ruri; Leja, Thomas W et al. (2014) Hhex and Cer1 mediate the Sox17 pathway for cardiac mesoderm formation in embryonic stem cells. Stem Cells 32:1515-26 |
| Zeve, Daniel; Seo, Jin; Suh, Jae Myoung et al. (2012) Wnt signaling activation in adipose progenitors promotes insulin-independent muscle glucose uptake. Cell Metab 15:492-504 |
| Verzi, Michael P; Stanfel, Monique N; Moses, Kelvin A et al. (2009) Role of the homeodomain transcription factor Bapx1 in mouse distal stomach development. Gastroenterology 136:1701-10 |
| Shah, Viraj R; Koster, Maranke I; Roop, Dennis R et al. (2007) Double-inducible gene activation system for caspase 3 and 9 in epidermis. Genesis 45:194-9 |
| Niu, Zhivy; Li, Ankang; Zhang, Shu X et al. (2007) Serum response factor micromanaging cardiogenesis. Curr Opin Cell Biol 19:618-27 |
| Chang, Jiang; Xie, Min; Shah, Viraj R et al. (2006) Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis. Proc Natl Acad Sci U S A 103:14495-500 |
| Zhang, Ying-Min; Bo, Jacqueline; Taffet, George E et al. (2006) Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. FASEB J 20:916-25 |
| Ilagan, Roger; Abu-Issa, Radwan; Brown, Doris et al. (2006) Fgf8 is required for anterior heart field development. Development 133:2435-45 |
| Garry, Daniel J; Masino, Amanda M; Naseem, R Haris et al. (2005) Ponce de Leon's Fountain: stem cells and the regenerating heart. Am J Med Sci 329:190-201 |
| Stanfel, M N; Moses, K A; Schwartz, R J et al. (2005) Regulation of organ development by the NKX-homeodomain factors: an NKX code. Cell Mol Biol (Noisy-le-grand) Suppl 51:OL785-99 |
Showing the most recent 10 out of 70 publications
